Analysts at Morgan Stanley lifted their rating on Bristol-Myers Squibb Company (BMY) to “overweight” from “equal weight”.
Major indices are mixed this Monday morning as talk of new production cuts has failed to stop the price of… Read More >
Stocks are higher this Friday morning as the world prepares for the inauguration of President Trump. The price of oil… Read More >
Bristol-Myers Squibb Company (BMY) shares are about to move higher if option traders are correct. OptionMonster highlighted a new vertical… Read More >